Back to Search Start Over

Effects of oral probiotic supplements on vaginal microbiota during pregnancy: a randomised, double-blind, placebo-controlled trial with microbiome analysis.

Authors :
Husain S
Allotey J
Drymoussi Z
Wilks M
Fernandez-Felix BM
Whiley A
Dodds J
Thangaratinam S
McCourt C
Prosdocimi EM
Wade WG
de Tejada BM
Zamora J
Khan K
Millar M
Source :
BJOG : an international journal of obstetrics and gynaecology [BJOG] 2020 Jan; Vol. 127 (2), pp. 275-284. Date of Electronic Publication: 2019 Apr 01.
Publication Year :
2020

Abstract

Objective: To determine the effects on the vaginal microbiota of an oral probiotic preparation administered from early pregnancy.<br />Design: Randomised, double blind, placebo-controlled trial.<br />Setting: Four maternity units in the UK.<br />Population: Women aged 16 years or older recruited at 9-14 weeks' gestation.<br />Methods: Participants were randomly allocated to receive oral capsules of probiotic containing Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 each at 2.5 × 10 <superscript>9</superscript> colony-forming units (CFUs) or placebo once daily from recruitment until the end of pregnancy.<br />Main Outcome Measure: Rates of bacterial vaginosis (BV, defined as Nugent score ≥7) at 18-20 weeks' gestation compared by logistic regression adjusted for possible confounders.<br />Results: The primary analysis included 78% (238/304) of participants who initially consented (probiotic group 123, placebo group 115). Of these participants, 95% (227/238) reported an intake of 93% or more of the required number of capsules. The rates of BV did not differ between groups at 18-20 weeks' gestation (15% (19/123) in the probiotic group vs. 9% (10/115) in the placebo group, adjusted odds ratio 1.82, 95% confidence interval 0.64-5.19). There were also no differences between the groups in the proportion of women colonised with the probiotic strains, Escherichia coli, group B streptococci or other vaginal microbiota. There were no differences in the alpha diversity or composition of the bacterial communities between or within the probiotic and placebo groups at 9-14 and 18-20 weeks' gestation.<br />Conclusions: Oral probiotics taken from early pregnancy did not modify the vaginal microbiota.<br />Tweetable Abstract: The oral probiotic preparation used in this study does not prevent BV in pregnant women.<br /> (© 2019 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists.)

Details

Language :
English
ISSN :
1471-0528
Volume :
127
Issue :
2
Database :
MEDLINE
Journal :
BJOG : an international journal of obstetrics and gynaecology
Publication Type :
Academic Journal
Accession number :
30932317
Full Text :
https://doi.org/10.1111/1471-0528.15675